Beruflich Dokumente
Kultur Dokumente
(Please note the ordering of drugs within each category is alphabetical and not intended to indicate a hierarchy of treatment)
Presentation
Clinically isolated syndrome Clinically isolated syndrome & RRMS: 1 relapse in last 2 years RRMS: 2 significant relapses
with multiple MRI lesions MRI activity, i.e McDonald MS AND radiological activity in last 2 years Rapidly evolving severe MS
within each category is alphabetical
Please note the ordering of drugs
Alemtuzumab [8]
First-line therapy
Beta-interferon [4]
No Treatment [1] No Treatment [1]
Dimethyl fumarate [5] Cladribine
Beta-interferon [6]
Beta-interferon [2] Glatiramer acetate Natalizumab
Teriflunomide
Alemtuzumab, rarely [3]
Alemtuzumab,
Alemtuzumab,
butrarely
see note
[7] [7]
Alternative First -line
therapy due to
See note 9
intolerance
Beta-interferon Alemtuzumab
Glatiramer acetate Cladribine
Teriflunomide Fingolimod
Dimethyl fumarate Natalizumab
(Daclizumab [14])
activity whilst on first-line therapy
Second-line therapy. For disease
Alemtuzumab Alemtuzumab
Cladribine [12] (Daclizumab [14])
Fingolimod [13]
(Daclizumab [14])
activity whilst on second-
continued inflammatory
Rescue therapy. For
No change [17]
Alemtuzumab
line therapy
Cladribine
Daclizumab [14]
Natalizumab [16]
Autologous haematopoietic stem cell transplant [15]